JP2001503011A - ペプチドと、その合成方法と、それをベースにした医薬品 - Google Patents
ペプチドと、その合成方法と、それをベースにした医薬品Info
- Publication number
- JP2001503011A JP2001503011A JP08503560A JP50356096A JP2001503011A JP 2001503011 A JP2001503011 A JP 2001503011A JP 08503560 A JP08503560 A JP 08503560A JP 50356096 A JP50356096 A JP 50356096A JP 2001503011 A JP2001503011 A JP 2001503011A
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cys
- phe
- ala
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.下記配列Iを有するペプチド: X-Tyr-Y-Phe-Z-A I (ここで、 AはOHまたは置換基を有するアミド(C1-C3)である) 2.請求項1に記載の配列Iで表されるペプチドの活性成分と 希釈剤または充填剤との混合物より成る医薬組成物。 3.液体である請求項2に記載の医薬組成物。 4.個体である請求項2に記載の医薬組成物。 5.注射液である請求項3に記載載の医薬組成物。 6.経口または非経口投与される請求項4に記載の医薬組成物。 7.ペプチド含有率が0.001%〜0.01%である請求項3に記載の医薬組成物。 8.ペプチド含有率が0.001%〜0.1%である実施例4に記載の医薬組成物。 9.C末端部分が置換基を有するアミドか保護されたカルボキシル基であり、こ れにN-保護されたフェニルアラニンを混合無水物法または活性エーテル法によっ て結合させ、次いでN-保護された基を取り除き、さらに活性エーテルまたは混合 無水物を添加した後にN-保護されたアミノ酸を添加し、N-保護された基を取り除 き、さらにN-保護されたアミノ酸を添加し、ペプチド鎖の合成が終了した後にテ トラまたはペンタペプチドを放出させ、パラジウム触媒を用いた水素化し、最終 生成物を得る、アミノ酸ZのC末端部分より開始してペプチド酸を除々に成長さ せる方法によって配列NO.1のペプチドを誘導する方法。 10.請求項9に記載の方法を無水溶液中で行い、その場合開始化合物はアミノ酸 のベンジルエーテルとトリブチロキシカルボニルフェニルアラニンとし、酸性溶 液中のトリブチロキシカルボニルを予め除去した後、この混合物にトリブチロキ シカルボニルフェニルアラニン酸を添加し、パラジウム触媒の存在下で水素を添 加し、イオン交換クロマトグラフィーによって最終生成物を得る方法。 11.吸着剤セファデックス(Sephadex G25)のカラムで0.1M〜1.0Mのピリジンア セテート濃度勾配を設けた緩衝溶液を用いたイオン交換クロマトグラフィーによ ってペプチドの精製を行う請求項10に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU94024278 | 1994-06-29 | ||
RU9494024278A RU2067000C1 (ru) | 1994-06-29 | 1994-06-29 | Пептид и способ его получения |
PCT/RU1995/000138 WO1996002267A1 (fr) | 1994-06-29 | 1995-06-27 | Peptide, son procede d'obtention et compose pharmaceutique a base dudit peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001503011A true JP2001503011A (ja) | 2001-03-06 |
JP3668950B2 JP3668950B2 (ja) | 2005-07-06 |
Family
ID=20157803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50356096A Expired - Fee Related JP3668950B2 (ja) | 1994-06-29 | 1995-06-27 | ペプチドと、その合成方法と、それをベースにした医薬品 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0779076B1 (ja) |
JP (1) | JP3668950B2 (ja) |
CN (1) | CN1165336C (ja) |
AT (1) | ATE290547T1 (ja) |
AU (1) | AU693576B2 (ja) |
CA (1) | CA2193969C (ja) |
DE (1) | DE69534061T2 (ja) |
DK (1) | DK0779076T3 (ja) |
ES (1) | ES2239760T3 (ja) |
HK (1) | HK1012551A1 (ja) |
PT (1) | PT779076E (ja) |
RU (1) | RU2067000C1 (ja) |
WO (1) | WO1996002267A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017502956A (ja) * | 2013-12-27 | 2017-01-26 | ステルス バイオセラピューティックス コープ | 薬学的に適切な芳香族カチオン性ペプチド |
US10633415B2 (en) | 2015-03-06 | 2020-04-28 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5868728A (en) * | 1995-02-28 | 1999-02-09 | Photogenesis, Inc. | Medical linear actuator for surgical delivery, manipulation, and extraction |
RU2107691C1 (ru) * | 1995-03-02 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
US6127339A (en) * | 1995-06-21 | 2000-10-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Peptide for binding thereto a low density lipoprotein |
WO1997010261A1 (fr) * | 1995-09-11 | 1997-03-20 | Daiichi Pharmaceutical Co., Ltd. | Derives peptidiques |
WO2000043352A1 (en) | 1999-01-22 | 2000-07-27 | Pharmacore, Inc. | A method for the synthesis of compounds of formula 1 and derivatives thereof |
US7473426B2 (en) | 2001-02-27 | 2009-01-06 | Yun Seok Choe | Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract |
WO2002067959A1 (en) * | 2001-02-27 | 2002-09-06 | Neurotide Co., Ltd. | Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and prepairing process thereof |
CN101627049B (zh) | 2006-11-10 | 2012-09-05 | 卡拉治疗学股份有限公司 | 合成酞酰胺 |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
KR102429287B1 (ko) * | 2015-12-10 | 2022-08-05 | 가부시끼가이샤 메니콘 | 펩티드 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8005121A (nl) * | 1979-09-20 | 1981-03-24 | Erba Farmitalia | Biologisch actieve peptiden. |
IE56021B1 (en) * | 1982-10-13 | 1991-03-27 | Akzo Nv | Peptides |
JPS59181293A (ja) * | 1983-03-31 | 1984-10-15 | Kyowa Hakko Kogyo Co Ltd | 新規生理活性蛋白性物質 |
FR2546756B1 (fr) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | Nouveaux derives immunostimulants, leur preparation et leur application comme medicament |
GB2146026A (en) * | 1983-09-07 | 1985-04-11 | Tanabe Seiyaku Co | Peptides and process for preparing the same |
DE3435727A1 (de) * | 1984-09-28 | 1986-04-10 | Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl | Pharmakologisch aktive peptide |
DE3841763A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
DE3841761A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
SE9300012D0 (sv) * | 1993-01-05 | 1993-01-05 | Astra Ab | New peptides |
-
1994
- 1994-06-29 RU RU9494024278A patent/RU2067000C1/ru active
-
1995
- 1995-06-27 AU AU29002/95A patent/AU693576B2/en not_active Ceased
- 1995-06-27 EP EP95924554A patent/EP0779076B1/en not_active Expired - Lifetime
- 1995-06-27 ES ES95924554T patent/ES2239760T3/es not_active Expired - Lifetime
- 1995-06-27 AT AT95924554T patent/ATE290547T1/de not_active IP Right Cessation
- 1995-06-27 DK DK95924554T patent/DK0779076T3/da active
- 1995-06-27 CA CA2193969A patent/CA2193969C/en not_active Expired - Fee Related
- 1995-06-27 CN CNB951943820A patent/CN1165336C/zh not_active Expired - Fee Related
- 1995-06-27 JP JP50356096A patent/JP3668950B2/ja not_active Expired - Fee Related
- 1995-06-27 PT PT95924554T patent/PT779076E/pt unknown
- 1995-06-27 DE DE69534061T patent/DE69534061T2/de not_active Expired - Lifetime
- 1995-06-27 WO PCT/RU1995/000138 patent/WO1996002267A1/ru active IP Right Grant
-
1998
- 1998-12-17 HK HK98113808A patent/HK1012551A1/xx unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017502956A (ja) * | 2013-12-27 | 2017-01-26 | ステルス バイオセラピューティックス コープ | 薬学的に適切な芳香族カチオン性ペプチド |
US10221213B2 (en) | 2013-12-27 | 2019-03-05 | Stealth Biotherapeutics Corp | Pharmaceutically relevant aromatic-cationic peptides |
US10696716B2 (en) | 2013-12-27 | 2020-06-30 | Stealth Biotherapeutics Corp | Pharmaceutically relevant aromatic-cationic peptides |
US10633415B2 (en) | 2015-03-06 | 2020-04-28 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
Also Published As
Publication number | Publication date |
---|---|
AU2900295A (en) | 1996-02-16 |
CN1165336C (zh) | 2004-09-08 |
ES2239760T3 (es) | 2005-10-01 |
HK1012551A1 (en) | 1999-08-06 |
WO1996002267A1 (fr) | 1996-02-01 |
JP3668950B2 (ja) | 2005-07-06 |
AU693576B2 (en) | 1998-07-02 |
DE69534061D1 (de) | 2005-04-14 |
CN1159758A (zh) | 1997-09-17 |
CA2193969C (en) | 2010-11-30 |
DE69534061T2 (de) | 2006-04-13 |
EP0779076B1 (en) | 2005-03-09 |
DK0779076T3 (da) | 2005-07-11 |
EP0779076A4 (en) | 1999-03-17 |
CA2193969A1 (en) | 1996-02-01 |
EP0779076A1 (en) | 1997-06-18 |
PT779076E (pt) | 2005-07-29 |
ATE290547T1 (de) | 2005-03-15 |
RU2067000C1 (ru) | 1996-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3668950B2 (ja) | ペプチドと、その合成方法と、それをベースにした医薬品 | |
DE69636343T2 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
DE69738326T2 (de) | Verbindungen und verfahren zur regulierung der zellanlagerung | |
JP2604457B2 (ja) | 毛の成長の刺激方法 | |
JP3902406B2 (ja) | 老化防御効果を示すテトラペプチド、これを基にした薬理学的物質、及びその利用法 | |
KR100543190B1 (ko) | 향상된생물학적효능을갖는키메라성지방체-프로-지알에프유사체 | |
CN104837485A (zh) | 血管紧张素在治疗脑部病况中的用途 | |
Schwyzer | Chemistry and metabolic action of nonsteroid hormones | |
US6184208B1 (en) | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide | |
JPH06502618A (ja) | 新規な合成grf類似物 | |
BG65137B1 (bg) | Антагонистични аналози на gh-rh инхибиращи igf-i и -ii | |
CA2418793C (en) | Pharmaceutical composition comprising an analgesic peptide | |
RU2362579C1 (ru) | Фармацевтическая композиция на основе пептида, обладающего противоопухолевым действием | |
CN101553127A (zh) | 用于改善繁殖效率的家畜管理 | |
NO177713B (no) | Analogifremgangsmåte ved fremstilling av hemoreguleringspeptider | |
RU2304444C1 (ru) | Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения | |
EA038745B1 (ru) | Конъюгат миноксидила и пептида | |
CN113134075B (zh) | 一种抗菌肽乳膏及其制备方法 | |
KR101054519B1 (ko) | 인간 성장호르몬―유래 펩타이드 및 이의 용도 | |
US6248716B1 (en) | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide | |
DE60018937T2 (de) | Somatostatin analoge und deren verwendung zur behandlung von krebs | |
DE60032822T2 (de) | Analoge der substanz p zur behandlung von krebs | |
EP1353939B1 (en) | Tetrapeptide regulating prostate functions and its compositions and uses | |
JPH09508142A (ja) | 抗腫瘍効果を有する新しいGnRH同族体およびその医薬品組成物 | |
RU2110275C1 (ru) | Способ получения пептида, обладающего анаболической активностью, стимулирующего увеличение массы тела, развитие эпидермального слоя и роста волосяного покрова |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040601 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040901 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20041018 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041001 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050118 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050127 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050329 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050401 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090422 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100422 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110422 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120422 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120422 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130422 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140422 Year of fee payment: 9 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |